2018 Annual Scientific Meeting of the Korean Society of Heart Failure

Daily Program

Scientific Program > Daily Program
Sep 16 (Thu), 2021
Grand Ballroom 1
14:50-15:00 Opening Remark
15:00-16:20 [IJHF Editorial Session]
Jump Up to the Global Platform		 최동주, 박성미
15:00-15:20 How to Get My Paper Accepted in JACC:HF Barry Greenberg
(USCD, JACC:HF, USA)
15:20-15:40 Common errors by Korean Authors 김휘출 (Editage)
15:40-16:00 Writing an Effective Response to Reviewers 황윤희 (Compecs)
16:00-16:10 How to incorporate IJHF for My Academic Achievement? 윤종찬 (IJHF 부편집장)
16:10-16:20 Discussion 김민석, 박진주, 이선기, 조동혁
16:20-16:30 Coffee Break
16:30-18:00 [English Session] [Joint Session with HFA]
Upcoming ESC HF Guidelines, What's New? 		Eun Seok JEON, Byung Su Yoo
16:30-16:45 Korean Perspective, Upcoming ESC HF Guidelines Cho, Hyun-Jai (Seoul National University)
16:45-17:00 What's New in HFrEF? Andrew Coats
(Univ of Warwick, UK)
17:00-17:15 What's New in HFpEF? Gerasimos Filippatos
(National & Kapodistrian Univ
of Athens, Greece)
17:15-17:30 Chronic or Acute HF? or HF Continuum Byung Su Yoo (Yonsei University Wonju)
17:30-18:00 Discussion Mi-Seung Shin, Jong-Chan Youn, Choi, Seonghoon
Grand Ballroom 2
15:00-16:20 [Joint Session with Endocrinology]
Crosstalk between Diabetes and HF		 강석민
15:00-15:15 Association between DM and HF 김현진 (한양의대)
15:15-15:30 DPP-4 inhibitor, GLP-1 Agonist in DM and HF 문준성 (영남의대)
15:30-15:45 SGLT2 Inhibitor in Patients with Type 2 Diabetes Mellitus – Endocrinologist 정인경(경희의대)
15:45-16:00 심부전 환자에서 SGLT2 Inhibitor - Cardiologist 최자연 (고려의대)
16:00-16:20 Discussion 전경현, 정혜문, 조성우, 최성훈
16:20-16:30 Coffee Break
16:30-18:00 [Joint Session with KSN - Nephrology] 양철우, 최동주
16:30-16:45 How to Manage Deteriorating Renal Function in Acute HF- Can Entresto Preserve Renal Function in Patients with Heart Failure ? 배은희 (전남의대)
16:45-17:00 Renal and Cardiovascular Effect of SGLT2 Inhibitors-Does SGLT2 Inhibitor Have Direct Effect on Heart and Kidney? 최대은 (충남의대)
17:00-17:15 Pharmacologic Treatment in Patients with HF with Advanced Renal Dysfunction 이상언 (울산의대)
17:15-17:30 Hyperkalemia in HF: Challenges and Management 김미나(고려의대)
17:30-18:00 Discussion 김응주, 김형종, 유태현, 최범순
Grand Ballroom 3
15:00-16:20 [English Session] [Joint Session with Cardio-oncology]
Cancer related Cardiac Failure		 Shin, Joon-Han, Ilsuk Sohn
15:00-15:15 Immune Checkpoint Inhibitor-Associated Myocarditis: Learning from Mice and Humans Javid Moslehi
(Vanderbilt Univ., USA)
15:15-15:30 Risk Stratification and Prevention of Myocardial Dysfunction in Cancer Patients Eun Kyoung Kim (Sungkyunkwan University)
15:30-15:45 Atrial Fibrillation during Chemotherapy: Risk and Benefit of Anticoagulation Jae-Sun Uhm(Yonsei University)
15:45-16:00 Multiple Myeloma and Cardiac Amyloidosis : Challenges of Management Thibaud Damy
(Assistance Publique des Hôpitaux de
Paris, France)
16:00-16:20 Discussion Bumsung Kim, Mi-Hyang Jung, Woo-Baek Chung
16:20-16:30 Coffee Break
16:30-18:00 [Joint Session with Korea Cardiogenic Shock Working Group]
Key Decision Making in the Management of Cardiogenic Shock with HF		 홍석근, 권현철
16:30-16:45 Fluid Therapy and New Emerging Drugs in Cardiogenic Shock with HF 배대환 (충북의대)
16:45-17:00 Efficacy of Novel Vasoactive Agents 강지훈 (서울의대)
17:00-17:15 Revascularization Strategies for Cardiogenic Shock Complicating AMI 양정훈 (성균관의대)
17:15-17:30 Double Bridge or Transplantation Bridged with ECMO 정재승 (고려의대)
17:30-18:00 Discussion 김민석, 안철민, 이수연, 정인석
Sep 17 (Fri), 2021
Grand Ballroom 1
08:20-08:50 강석민
08:20-08:50 Lower is better & Earlier is better 신성희 (인하의대)
08:50-09:00 Break Time
11:30-12:10 Yong-Jin Kim, Jin-Oh Choi
11:30-11:45 Importance of Pressure-Volume (PV) Loops Adam G. Goodwill
(Northeast Ohio Medical Univ., USA)
11:45-12:00 Left Ventricular PV Loop Estimation in HF Management In-Cheol Kim (Keimyung University)
12:00-12:10 Disscusion Chi-Young Shim, Sang-Ho Jo, Jae Yeong Cho
12:10-13:00 신준한, 박대균
12:10-12:30 Recent advances in cardiac amyloidosis based on 2021 ESC updates 김다래 (성균관의대)
12:30-12:50 How we can treat ATTR-CM in Korean clinical practice 손정우 (연세원주의대)
12:50-13:00 Q&A / Discussion
13:00-14:00
14:00-15:20 Seok Min Kang, Seung Shin
14:00-14:15 Transcriptional Circuits Underlying Heart Failure Koichiro Kuwahara
(Shinshu Univ., Japan)
14:15-14:30 Novel Devices in HF Sunki Lee (Hallym University)
14:30-14:45 Recent Clinical Trials of Pharmacologic Therapy for Heart Failure Hiroyuki Tsutsui
(Kyushu Univ., Japan)
14:45-15:00 Strain Imaging as a New HF Classification Jae-Hyeong Park (Chungnam National University)
15:00-15:20 Discussion Sung Hea Kim, Hyung Yoon Kim, Chan Seok Park, Jah Yeon Choi
15:20-15:30 Coffee Break
15:30-17:00 유병수, 양동헌
15:30-16:00 HFpEF에서 ARNI vs. non-ARNI
15:30-15:45 Pro. ARNI가 도움이 된다. 박진주 (서울의대)
15:45-16:00 Con. ARNI가 도움이 되지 않는다. 조동혁 (연세원주의대)
16:00-16:30 Beta-blocker Titration Strategy, Early use of Ivabradine
16:00-16:15 Pro. Early combination of ivabradine 전경현 (일산병원)
16:15-16:30 Con. Late combination of ivabradine 이주희 (충북의대)
16:30-17:00 Discussion 박성지, 이찬주, 정혜문, 조상호
17:00-17:10 Break Time
17:10-18:40 김재중, 강석민
17:10-17:25 Brain Death Organ Donation: Current Status and Improvement 정성호(울산의대)
17:25-17:40 국내 심장이식 현황, 예후 및 개선 방안 오재원 (연세의대)
17:40-17:55 심실 보조장치 치료술(VAD) 요양급여 현황 이상문(건강보험심사평가원)
17:55-18:10 Korean LVAD registry 수립 방안 조양현 (성균관의대)
18:10-18:40 Discussion 김민석, 윤영남, 윤오혁, 최진오
Grand Ballroom 2
09:00-09:50 최성훈
09:00-09:15 Setup Methodology for HF Fact Sheet 박진주 (서울의대)
09:15-09:35 Korean HF 2020 Fact Sheet 최진오 (성균관의대)
09:35-09:50 Discussion 고충원, 김현창, 박성미
09:50-11:10 Oh, Byung-Hee, Se Joong Rim
09:50-10:20 New HFpEF Diagnosis Concept. Is the Classification based on Ejection Fraction Kept on? Andrew Coats (Univ of Warwick, UK)
10:20-10:50 Pharmacological Treatment of HFpEF Stefan D. Anker
(Charite, Germany)
10:50-11:10 Discussion Kye Hun Kim, Sung-Ji Park, Wook-Jin Chung
11:10-11:30 Coffee Break
11:30-12:10 김동수, 최성훈
11:30-11:45 Practical Management of ECMO in Aborted Sudden Cardiac Death 김민석 (울산의대)
11:45-12:00 Start ECMO in Left Heart Decompression: When, How ? 박명수 (한림의대)
12:00-12:10 Discussion 김진진, 위진, 박상민, 홍정애
12:10-13:00 강석민, 양동헌
12:10-12:35 Maximizing reverse cardiac remodeling effect with ARNI in Heart Failure James Januzzi
(Harvard Medical School, Massachusetts General Hospital, USA)
12:35-13:00 Optimal Treatment of heart failure according to 2021 ESC Heart Failure Guideline John J. V. McMurray
(University of Glasgow. UK)
14:00-15:20 Eun Seok JEON, Jae-Joong Kim
14:00-14:15 Utilization of Marginal Donors in Heart Transplantation Jon Kobashigawa
(Cedars-Sinai Smidt Heart Institute, USA)
14:15-14:30 Current Status of Heart Transplantation and LVAD in Korea Jin-Oh Choi (Sungkyunkwan University)
14:30-14:45 The Right Ventricle and LVAD Therapy Mandeep R Mehra
(Brigham and Women’s Hospital and Harvard Medical School., USA)
14:45-15:00 Palliative Management in End Stage HF Patients Soo Yong Lee (Pusan National University)
15:00-15:20 Discussion Min-Seok Kim, In-Cheol Kim, Jong-Chan Youn, Jung, Sung-Ho
15:20-15:30 Coffee Break
15:30-17:00 홍경순, 박대균
15:30-15:45 Initial Phenotyping and Therapeutic Decision Making in HFpEF 최정현 (부산의대)
15:45-16:00 Echocardiography for CIED 김형윤 (전남의대)
16:00-16:15 Decision Making in Critically Ill Patients 신성희 (인하의대)
16:15-16:30 The Use of Echocardiography in Post Heart Transplantation 심지영 (연세의대)
16:30-17:00 Discussion 김미정, 김혜미, 조은정, 하상진
17:00-17:10 Break Time
17:10-18:40 최동주, 김응주
17:10-17:30 Where to Go, Al Health in Korea. 이주희 (국립보건연구원)
17:30-17:50 Digital Healthcare, the Future of Medicine 최윤섭
((주)디지털 헬스케어 파트너스(DHP))
17:50-18:10 디지털 헬스케어의 적용 사례 최두아(휴레이포지티브)
18:10-18:40 Discussion 김인철, 박준범, 심지영, 이선기
Grand Ballroom 3
08:20-08:50 김계훈
08:20-08:50 State-of-the-art fact findings in T2D with Heart Failure Stefan D. Anker
(Charite, Germany)
08:50-09:00 Break Time
09:00-09:50 Eun Seok JEON, Sung Kee Ryu
09:00-09:20 Introduction of ESC (or HFA) Educational Program Giuseppe Rosano
(St George’s University Medical School of London, UK)
09:20-09:35 Current Status and Future Trends of Cardiology Training in Korea Shinki An (Yonsei University)
09:35-09:50 Setting Up of Early Career as a Heart Failure Specialist Kyung-Hee Kim (Incheon Sejong Hospital)
09:50-11:10 채성철, 김명아
09:50-10:05 Selected Abstract 1 Selected Abstract Speaker 1
10:05-10:20 Selected Abstract 2 Selected Abstract Speaker 2
10:20-10:35 Selected Abstract 3 Selected Abstract Speaker 3
10:35-10:50 Selected Abstract 4 Selected Abstract Speaker 4
10:50-11:10 Discussion 박성미, 박재형, 양동헌, 유승기
11:10-11:30 Coffee Break
11:30-12:10 김영대, 황진용
11:30-11:45 Novel Biomarkers for Risk Stratification in HF 김봉준 (고신의대)
11:45-12:00 Biomarkers; What's Different between HFpEF and HFrEF 황석재 (경상의대)
12:00-12:10 Discussion 김창연, 서석민, 조동혁, 최재혁
12:10-13:00 김명아, 유병수
12:10-12:30 Beta-Blocker in Patients with Cardiac Arrhythmias 최종일 (고려의대)
12:30-12:50 Recent Update on OAC Therapy 조익성 (연세의대)
12:50-13:00 Discussion 김응주, 조동혁
14:00-15:20 [Joint Session with CS - CV Surgery]
Challenges of Cardiac Surgery for HF		 윤영남, 김동수
14:00-14:15 CABG for Ischemic Cardiomyopathy 윤영남(연세의대)
14:15-14:30 Role of MitraClip: Surgeons's View 김준범(울산의대)
14:30-14:45 AVR for DCMP Patients 김준성 (서울의대)
14:45-15:00 Post-cardiotomy ECMO 정인석(전남의대)
15:00-15:20 Discussion 김계훈, 김환욱, 손석호, 허란
15:20-15:30 Coffee Break
15:30-17:00 Cardiology Special Nurse Session 최의영, 김현주
15:30-15:45 Role of HF Coordinating Nurse in-hospital and Outpatients Clinic  서명주(부천세종병원)
15:45-16:00 Nursing Care for pre/post Heart Transplantation in General Ward 장다엘(세브란스병원)
16:00-16:15 Management of pre- and Post-LVAD Patients 최남경 (삼성서울병원)
16:15-16:30 Role of Special Nurse in Cardiac Rehabilitation   김지수(세브란스병원)
16:30-16:45 How to Make a Career as a HF Special Nurse, Research Experiences 안정아(아주대병원)
16:45-17:00 Discussion 공지은, 손연정, 옥종선, 이경은, 임안나
17:00-17:10 Break Time
17:10-18:40 조명찬, 유병수
17:10-17:25 Gender specific HF treatment strategy 김학령(서울의대)
17:25-17:40 RFA of atrial fibrillation and single nucleotide polymorphism 최종일(고려의대)
17:40-17:55 Precision Medicine in Pulmonary Hypertension 정욱진(가천의대)
17:55-18:10 Emerging Roles of Biomarkers in Heart Failure 조동혁(연세원주의대)
18:10-18:40 Discussion 공민규, 최성훈, 최의영
Sep 18 (Sat), 2021
Grand Ballroom 1
08:20-08:50 Morning Review III – SERVIER 신미승
08:25-08:45 Tailored treatment for heart failure with elevated HR 김현진 (한양의대)
08:45-08:50 Discussion
08:50-09:40 Hot Topic Session (I) – Novartis 김명아
08:50-09:20 How should I Treat My HFrEF Patients with All New Consensus and Guideline Barry Greenberg
(USCD, JACC:HF, USA)
09:20-09:40 Discussion 김인철, 박진주
09:40-09:50 Break Time
09:50-11:10 [English Session]
Plenary Session III - HFrEF		 Kyu Hyung Ryu, Dong-Ju Choi
09:50-10:20 Optimal HFrEF Treatment, New Perspectives James Januzzi (Harvard University, USA)
10:20-10:50 Role of SGLT2I from Chronic to Acute HF, Where Is Proper Position in GDMT? Michael Bohm
(Saarland University, Germany)
10:50-11:10 Discussion Seong-Mi Park, Jong-Chan Youn, Jae Yeong Cho, Jung Hyun Choi
11:10-11:30 Coffee Break
11:30-12:10 [English Session]
Satellite Symposium IV - Gene		 Choong-Won Goh, Eui-Young Choi
11:30-11:45 Update on the Genetic Evaluation of Dilated Cardiomyopathy Ray Hershberger
(Ohio State Univ., USA)
11:45-12:00 Real Cases of Gene Testing, Treatment, Counseling: Online Live Discussion Jaewon Oh (Yonsei University)
12:00-12:10 Discussion Jin Joo Park, Ju-Hee Lee, Hyemoon Chung
12:10-13:00 Luncheon Session IV - AstraZeneca 김동수, 강석민
12:10-12:35 Saving Lives, Hearts and Kidneys with Dapagliflozin 윤종찬 (가톨릭의대)
12:35-13:00 Re-defining role of Candesartan from Hypertension to Heart failure 김지희 (가톨릭의대)
13:00-13:50 Brightening Clinical HF Case Presentation
13:50-15:20 [English Session] [Joint Session with HFSA]
Quadruple Therapy for HFrEF Patients		 IHM, Sang Hyun, Wook-Jin Chung
13:50-14:10 Challenge of Prescribing Inertia: from CHAMP-HF Registry Biykem Bozkurt
(Baylor College of Medicine,
USA)
14:10-14:25 Performance Measures for HF Management in Korea Jae Yeong Cho (Chonnam National University)
14:25-14:45 Benefits of Quadruple Therapy for HFrEF JoAnn Lindenfeld(Vanderbilt
University Medical Center,
USA)
14:45-15:00 Comprehensive or Stepwise Treatment for HFrEF Jung-Hyun Choi (Pusan National University)
15:00-15:20 Discussion Mingyu Kong, Eun Kyoung Kim, Sang-Hoon Seol, Hyeonju Jeong
15:20-15:30 Coffee Break
15:30-16:50 [English Session]  [Joint Session with ISHLT]
Challenges in Heart Transplantation & MCS		 Jae-Joong Kim, Seok Min Kang
15:30-15:45 The Heart Transplant Donor Shortage: Challenges to Overcome Kiran Khush
(Stanford Univ, USA)
15:45-16:00 Challenge & Overcome of Donor Shortage in Korea Kyung-Hee Kim (Incheon Sejong Hospital)
16:00-16:15 Future Perspective in MCS Howard J. Eisen (Pennsylvania
State Univ., USA)
16:15-16:30 Pulmonary Hypertension in Heart Transplantation and Mechanical Cardiac Support Darae Kim (Sungkyunkwan University)
16:30-16:50 Discussion Jong-Chan Youn, Hye Won Lee, Jung, Sung-Ho, Jin-Oh Choi
17:00-18:30 [English Session]  [Joint Session with CHFA]
Contemporary HF Etiology of Eastern Asian		 SHIN, Dong-Gu, Eung Ju Kim
17:00-17:15 Ischemic Cardiomyopathy Yuhui Zhang
(Fu Wai Hospital, China)
17:15-17:30 Idiopathic Dilated Cardiomyopathy Sang Eun Lee (Ulsan University)
17:30-17:45 Acute and Chronic Myocarditis Jian Zhang
(Fu Wai Hospital, China)
17:45-18:00 Hypertrophic Cardiomyopathy In-Cheol Kim (Keimyung University)
18:00-18:30 Discussion Kyung-Jin Kim, Jiwon Seo, Jung-Woo Son
Grand Ballroom 2
11:30-12:10 Myung-A Kim, Seok Min Kang
11:30-11:45 Smartphone Application for Cardiac Rehabilitation: Strength and Weakness Eung Ju Kim (Korea University)
11:45-12:00 Skeletal Muscle and Prognosis of HF: Can Cardiac Rehabilitation Overcome Muscle Wasting? Kazunori Shimada
(Juntendo University Hospital,
Japan)
12:00-12:10 Discussion Kyung-Jin Kim, Yoonjee Park, Chan Joo Lee/td>
12:10-13:00 홍석근
12:10-12:35 Sympathetic overdrive and the role of Beta-blockers 오재원 (연세의대)
12:35-13:00 Anticoagulation therapy in HF with AF 정혜문 (경희의대)
13:50-15:20 홍석근, 최기준
13:50-14:05 Clinical Role of CRT for Non-Ambulatory Class IV HF Patients 박승정(성균관의대)
14:05-14:20 Update on Clinical Benefit of ICD in Patients with HF 엄재선(연세의대)
14:20-14:35 Remote Monitoring in Patient with HF 김성환 (가톨릭의대)
14:35-14:50 Managing CIED Detected Atrial Fibrillation in Patients with HF 심재민 (고려의대)
14:50-15:20 Discussion 김윤기, 김진배, 박상원, 최영
15:20-15:30 Coffee Break
15:30-16:50 Seongwoo Han
15:30-15:45 Mechanistic Background of the Benefit of SGLT2 Inhibitors: Non-cardiac effect Sung Hee Choi (Seoul National University)
15:45-16:00 Benefit of SGLT2 Inhibitors across the Cardiorenal Continuum Hyuk-Sang Kwon (Catholic University)
16:00-16:15 Mechanistic Background of the Benefit of SGLT2 Inhibitors: Cardiac Effect Iksung Cho (Yonsei University)
16:15-16:30 Positioning of SGLT2 Inhibitors in HF Management: How Should We Sequence? John J.V. McMurray
(University of Glasgow., UK)
16:30-16:50 Discussion Sung-Ji Park, Hun-Jun Park, Mi-Hyang Jung, Hong-Mi Choi
16:50-17:00 Break Time
17:00-18:30 주승재, 황경국
17:00-17:15 Comorbidities in HF: Evidence and Guidelines 한성우(한림의대)
17:15-17:30 Myocardial Iron Depletion and HF: Impelenting Guideline 이찬주(연세의대)
17:30-17:45 Family Involvement in Heart Failure Management 손연정(중앙대 간호대)
17:45-18:00 Intervention to Address Frailty in HF Anna Stromberg
(Linkoping Univ., Sweden)
18:00-18:30 Discussion 김다래, 김봉준, 박명수, 최의영
Grand Ballroom 3
08:20-08:50 정욱진
08:20-08:50 Prime time of SGLT2 inhibitors in T2D with Heart Failure 윤종찬 (가톨릭의대)
08:50-09:40 강석민, 박성미
08:50-09:10 Identifying and Diagnosing ATTR-CM in Clinical Practice 김미나 (고려의대)
09:10-09:30 Recent Advances in Treating and Managing ATTR-CM 오재원 (연세의대)
09:30-09:40 Q&A / Discussion
09:40-09:50 Break Time
09:50-11:10 박대균, 박성지
09:50-10:05 심부전치료: 생존율 개선을 위한 약물 현준호(울산의대)
10:05-10:20 Treatment of Heart Failure, Focus on Symptom Management 허란(한양의대)
10:20-10:35 Refer Cases Focused 1: 경증질환 중심 최홍미(한림의대)
10:35-10:50 Refer Cases Focused 2: 경증질환 중심 김현진(한양의대)
10:50-11:10 Discussion 김미나, 박상민, 안효석
11:10-11:30 Coffee Break
11:30-12:10 Sukkeun Hong
11:30-11:45 Practical Tips and Current Recommendation on How to Manage VAD Infection: from Device Infection to Pump Infection Yang Hyun Cho (Sungkyunkwan University)
11:45-12:00 Allograft Dysfunction: A Clinician's Approach to a Common Dilemma Christopher S. Hayward
(St. Vincent's Hospital, Australia)
12:00-12:10 Discussion Darae Kim, Woo Sung Jang, Choi, Yun-Seok
12:10-13:00 정욱진
12:10-12:35 Anti-Coagulation in Different Patient Populations : Afib with Co-Morbidity 박성미 (고려의대)
12:35-13:00 Prevention of stroke in elderly: Focus on Frailty and Advanced Age 최정현 (부산의대)
13:50-15:20 조상호,신동호
13:50-14:05 Treatment of Patients with Acute Heart Failure with Reduced Renal Function 강민경(한림의대)
14:05-14:20 ADHF: 폐질환이 동반된 급성심부전 환자 치료 이종찬(서울의대)
14:20-14:35 ADHF: 간질환이 동반된 급성심부전 환자 치료 김민관(연세의대)
14:35-14:50 Hurdles in Treating with Guideline Directed Medicine 온정헌(서울의대)
14:50-15:20 Discussion 김지희, 류동열, 황승하
15:20-15:30 Coffee Break
15:30-16:50 HAN, Kyoo-Rok, Mi-Seung Shin
15:30-15:45 Transcatheter Treatment of Heart Failure Using a Novel Interatrial Implant to Lower Left Atrial Pressure Lars SØndergaard
(Rigshospitalet, Denmark )
15:45-16:00 Percutaneous Edge-to-Edge Mitral Valve Repair for functional MR Khung Keong Yeo
(National Heart Centre Singapore, Singapore)
16:00-16:15 Perspective of Tricuspid Regurgitation in Right Side HF Jung Yeon Chin (Eulji University)
16:15-16:30 New Device Management of Tricuspid Regurgitation Kiyuk Chang (Catholic University)
16:30-16:50 Discussion Do-Yoon Kang, Jung-Sun Kim, Young Sup Byun, Choi, Yun-Seok
16:50-17:00 Break Time
17:00-18:30 김재중
17:00-17:15 Overview for major changes in new guidelines 최성훈(한림의대)
17:15-17:30 4 Pillar Early treatment in HFrEF 김민석(울산의대)
17:30-17:45 Specific HF tailored treatment 윤종찬(가톨릭의대)
17:45-18:00 Targeted therapy for specific cardiomyopathy 정미향(한림의대)
18:00-18:30 Discussion 강석민, 유병수, 최동주, 최진오
Scientific
Program